Therapeutic Asset Ratings
1,553 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Dupilumab
Triple-Negative Breast Carcinoma
Rima Patel
Early P1
C
(39)
Ebv Mrna Vaccine
HIV-Associated Cancer
West China Hospital
Early P1
C
(39)
Ebv Tcr-T
Diffuse Large B-Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Early P1
C
(39)
Ebv Tcr-T
Extranodal Nasal NK/T Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Early P1
C
(39)
Ebv Tcr-T
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Early P1
C
(39)
Egfr/B7H3 Car-T
Lung Cancer
Second Affiliated Hospital of Guangzhou Medical University
Early P1
C
(39)
Egfr/B7H3 Car-T
Triple-Negative Breast Carcinoma
Second Affiliated Hospital of Guangzhou Medical University
Early P1
C
(39)
Eloxatin
Advanced Prostate Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Eloxatin
Mucositis
Tanta University
Early P1
C
(39)
Encorafenib
Skin Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Early P1
C
(39)
Entrectinib
Ovarian Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Entrectinib
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Entrectinib
Prostate Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Entrectinib
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Epigallocatechin-3-Gallate
Breast Cancer
Ministry of Health, Saudi Arabia
Early P1
C
(39)
Epinephrine
Facelift Surgery
University of Minnesota
Early P1
C
(39)
Epinephrine
Hemorrhage
University of Minnesota
Early P1
C
(39)
Epinephrine
Obesity Disorder
IVO JURISIC
Early P1
C
(39)
Epirubicin
Carcinoma, Intraductal, Noninfiltrating
Laura Esserman
Early P1
C
(39)
Epirubicin
Identified by NGS, PCR or IHC
Memorial Sloan Kettering Cancer Center
Early P1
C
(39)
Epirubicin
Pediatric AML
Joanna Yi
Early P1
C
(39)
Epirubicin
Smoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center
Early P1
C
(39)
Eribulin
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Eribulin
Prostate Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
ETOPOSIDE
Grade II Glioma
Oliver Jonas
Early P1
C
(39)
Showing 426 to 450 of 1,553 assets
Previous
Page 18 of 63
Next
